Health 2.0 Conference’s Spring Edition Addressed Pharma Scams & Frauds

The pharmaceutical industry is one of the world’s most alluring and fastest-growing healthcare sectors. Although they generate revenue of billions of dollars every year, some pharma people look out for ways to scam insurers and patients to earn more. Healthcare experts have taken the initiative at various healthcare events in 2022 to highlight these pharma scams and look forward to bringing awareness about these scams and frauds, which are affecting the trust and reliability of people in the healthcare industry.

Let’s delve deeper into the common healthcare scams and frauds shared at Health 2.0 Conference to identify and keep ourselves away from such scams.

  • Illegitimate Kickbacks

Illegitimate kickbacks encourage healthcare professionals to consider their profits over patients’ health. It leads to directing medicines in higher doses or for more extended periods than genuinely needed by an individual. This influential doctor’s behavior results from some additional advantages or bribes given to them by the pharmaceutical company to boost their product’s sales highlighted by healthcare experts at Health 2.0 Conference. In this scam, pharma companies offer monetary and in-kind bribes like luxurious vacations, expensive gifts, free equipment, and even unrestricted grants.

  • Fraud In Clinical Trials

It is mandatory for medicine manufacturers to obtain approval from the FDA before marketing their medicines. Considering the medicine’s safety, efficiency, pharmacology, toxicology, and many other factors, the FDA approves new medications after positive clinical trials, testing, and analysis depending on the medicine manufacturers’ New medicine Applications (NDA). It is where medicine companies take advantage and try to make fraud statements, manipulate the relevant data, or omit the safety and efficiency of the medicines, which is subject to False Claims Act (FCA) liability. Health experts at Health 2.0 Conference highlighted that mecine companies often pay researchers to be fake the clinical trial results. 

  • Off-Label Marketing Scam

Off-label marketing fraud is when medicine companies or medical device manufacturers market and promote the implementation of an FDA-approved controlled substance device for a purpose other than the FDA’s approval. medicine companies or medical device manufacturers try to gain enormous profits when they believe that their FDA-approved medicines or devices are effective for other unapproved uses. It is why many companies are motivated to involve in off-label marketing, which is unlawful and may affect patient’s safety, underlined healthcare professionals at Health 2.0 Conference. 

  • Medicare Best Price Scam

Medicine manufacturers that engage in the Medicare Rebate Program are needed by law to accurately submit their lowest available prices for the medicines they make and sell. According to law, they are also supposed to give rebates to patients who bought medicines above these reported prices. This initiative is taken to help retired or disabled people so that they can pay the lowest prices for their medications, thus making their treatment an economic practice.

Manufacturers declare the best prices while considering details like:

  • Discounts
  • Coupons
  • Grants
  • Other incentives

Whereas in reality, these discounts, coupons, offers, and many more benefits are just an opportunity for medicine companies to conduct fraud, underlines experts at Health 2.0 Conference while supplying the medications.

These manufacturers first report high prices for their medications to avail of maximum benefits from the rebate programs. As they offer heavy discounts and offers, it becomes difficult to know whether the manufacturers are declaring the correct prices and providing suitable recommendations or are just playing with the numbers for personal benefits. It is why this is one of the most difficult to uncover types of pharmaceutical fraud. Most such cases are only prosecuted, thanks to the assistance of whistleblower lawsuits.

  • Medicare Prescription medicine Program Fraud

Under the Medicare Prescription Program, about tens of millions of elderly and disabled Americans are provided medicine coverage. Private insurance companies—Part D Sponsors—offer prescription medines to eligible beneficiaries directly or through pharmacy benefit managers (PBMs) and then submit claims to Medicare for the medines’ cost. Fraud can occur under Medicare Part D in many ways, including:

Most common types of Medicare Part D program fraud were highlighted at the Health 2.0 Conference:

  • Billing for medicines that were not provided.
  • Billing for medicines that Medicare does not cover.
  • Billing for brand name medicines.
  • Billing for illicit medicines that are used for unlawful purposes.
  • Billing for expired medicines.
  • Billing for medicines without a prescription or with fake medicine.
  • Billing for medicines with prescriptions from unauthorized, excluded, or fraudulent healthcare providers.
  • Billing for excessive medicine than the approved limits.
  • Illicit medicine-Switching

Medicine switching is another malpractice in which pharmacists try to substitute the patients’ medicines, like replacing a generic medicine with a brand name or suggesting liquid form over solid pills. Doing such things while keeping the patient’s health at stake is considered an FCA violation.

  • Compounded medicine Scam

Compounding is the practice of blending different pharmaceutical ingredients into a single form or dosage to fulfill a specific patient’s needs. For example, a person who would otherwise find it challenging to have so many medicines for one problem can get this compounded medicine for their treatment.

As these medicines are personalized as per the patient’s needs, it becomes complicated for the FDA to test and approve all the personalized medications; thus, these compounded medicines are not tested by the FDA. The FDA allows medicine manufacturers to sell compounded medications without approval for people’s health benefits. In return, medicine companies try to earn profits from these compounded medicines by conducting scams.

Manufacturers are responsible for fixing the charges of these compounded medicines, and they set them as high as possible to earn more money. Also, some experts at healthcare events of 2022 revealed that some scams involve doctors as well, where the medicine companies bribe them to prescribe their expensive compounded medicines to the patients. So, the company and doctor can get enough profits at the expense of the patient’s health. 

  • Good Manufacturing Practice Offense

The federal government demands medicine manufacturers to stick to various stringent rules for the safety of the public, known as Current Good Manufacturing Practice (CGMP) regulations.

CGMP Regulations Include:

  • Need to have fully equipped and good state manufacturing facilities.
  • Hire trained personnel as the staff.
  • Maintain stringent control at every step of the manufacturing process.
  • Keeping lab controls in place, along with accurate records, is also essential.
  • Timely submissions of examinations of their final products.

If, by any chance, medicine companies overlook or willingly skip over some or all of these regulations, they will be violating the Good Manufacturing Practice and making an offense. For which they would be fined or shut down for committing healthcare fraud, stated at Health 2.0 Conference.

  • Auto-Refilling Scam

Patients who have chronic health conditions like asthma or diabetes participate in the auto-refilling programs available from their pharmacies. In these programs, patients can get their prescriptions refilled each month automatically without calling in, visiting, or going online to order new refills.

This program turns into a healthcare scam when pharmacies continue to refill these prescriptions even after the patients stop taking their auto-refill medications. In this offense, pharmacies keep billing insurance like Medicare or Medicaid for their auto-refill. After that, they sell the prescription to another patient while gaining profit.

Many times, pharmacies continue to engage in such fraud until they reach a maximum number of refills for a particular prescription or until it expires. As it is a violation of the FCA (False Claims Act) when caught, they are heavily charged and, in some cases, are shut down due to these auto-refill frauds, professionals shared at Health 2.0 Conference.

Prevention Methods Against Pharma Scams, Highlighted At Health 2.0 Conference

As these healthcare scams can have a substantial adverse effect on an individual’s health, one needs to take action to control these pharmaceutical scams. Health 2.0 Conference suggested a few ways to get a hold of these scams.

  • Setting up a secure and anonymous complaint platform for people to notify of these fraudulent behaviors.
  • A reporting tool can also boost prevention efforts.
  • One can monitor a doctor’s referrals and sales reps to know about the companies which are paying them to track the trends and areas of risk related to the kickbacks before they turn into legal concerns.
  • Random visits to the medicine companies or their research sites to check the authenticity and relevance of their result reports.
  • Some healthcare experts at the Health 2.0 Conference suggested heavy fines and punishments against the scammers, which would discourage others from conducting such healthcare frauds.
  • One primary reason why these pharmaceutical companies are able to conduct these healthcare scams is due to negligence and ignorance of the people. People need to be cautious while asking for medications.
  • Apart from these, the government needs to put strict checks on pharmaceutical companies and doctors to avoid their unhealthy collaborations to play with people’s health and safety.

These are a few ways to keep these pharma frauds under control and prevent people’s health and safety. For more information and knowledge on healthcare and related sectors, one can always plan to attend this biggest in-person event, Health 2.0 Conference, scheduled for December 2022 in the USA and Dubai. 

Leave a Reply

Your email address will not be published. Required fields are marked *